Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-03-20
1999-08-03
Gupta, Yogendra N.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
5142358, 514255, 514326, 514341, 514342, 514343, 514370, 514392, 514400, 544120, 544131, 544132, 544405, 544406, 544407, 546208, 5462727, 5462751, 548195, 5483381, 5483315, 548204, A61K 31415, A61K 31495, C07D40312
Patent
active
059326069
ABSTRACT:
A compound which inhibits human thrombin and where has the structure and pharmaceutically acceptable salts thereof, wherein such as ##STR1## which are useful for inhibiting formation of blood platelet aggregates in blood in a mammal.
REFERENCES:
patent: 5260307 (1993-11-01), Ackermann et al.
patent: 5405854 (1995-04-01), Ackermann et al.
patent: 5510369 (1996-04-01), Lumma et al.
Dorsey Bruce D.
Isaacs Richard C. A.
Naylor-Olsen Adel M.
Newton Christina L.
Gupta Yogendra N.
Merck & Co. , Inc.
Parr Richard S.
Winokur Melvin
LandOfFree
Pyrazinone, pyridinone, piperidine and pyrrolidine thrombin inhi does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrazinone, pyridinone, piperidine and pyrrolidine thrombin inhi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrazinone, pyridinone, piperidine and pyrrolidine thrombin inhi will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-849876